GENE ONLINE|News &
Opinion
Blog

2026-04-15|

Hybrid Hub Models on the Rise as 2026 Patient Services Report Highlights Technology Gaps and Interoperability Challenges

by GOAI
Share To

A recent survey conducted by CareMetx, involving over 100 patient access decision-makers from biopharma, consulting, and specialty care sectors, highlights significant shifts within the industry. The findings, detailed in the *2026 Patient Services Report*, reveal that hybrid hub models are increasingly becoming standard practice. However, technology adoption across patient services remains inconsistent, and interoperability is emerging as a key factor for driving meaningful advancements in patient access.

The report underscores an industry undergoing transformation. Hybrid hub models—systems combining traditional centralized hubs with decentralized elements—are gaining traction as organizations seek more flexible approaches to patient support. Despite this progress, the survey indicates uneven implementation of technology solutions across the sector. Many organizations face challenges in fully integrating digital tools into their workflows. Additionally, interoperability—the ability of different systems and technologies to work seamlessly together—is identified as a critical barrier to achieving streamlined operations and improved outcomes for patients. These findings suggest that while innovation is occurring, significant hurdles remain in creating cohesive and efficient systems for patient access.

Further insights from the report are available through CareMetx’s publication of the full *2026 Patient Services Report*.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 20, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
MoonLake Immunotherapeutics Concludes Pre-BLA Meeting with FDA and Reports Q1 2026 Financial Results
2026-05-10
New Method Allows Repeated Genetic Data Extraction From Living Cells Without Destruction
2026-05-10
Scroll to Top